Previous Close | 0.1000 |
Open | 0.1000 |
Bid | 0.0950 x N/A |
Ask | 0.1050 x N/A |
Day's Range | 0.1000 - 0.1000 |
52 Week Range | 0.0650 - 0.4500 |
Volume | 10,000 |
Avg. Volume | 94,752 |
Market Cap | 6.319M |
Beta (5Y Monthly) | 1.42 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0320 |
Earnings Date | Apr. 23, 2019 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / January 21, 2021 / Pascal Biosciences, Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:BIMUF), will present at the first Cannabinoid Derived Pharmaceuticals Industry Review Summit today.
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / December 8, 2020 / December 2, 2020 / Pascal Biosciences Inc.
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / November 10, 2020 / Pascal Biosciences Inc.